Phase 3 Study of MDMA Proves Clinically Effective (May 10th)
www.thehealthcarepolicypodcast.com
Listeners may recall I interviewed Dr. Rick Doblin in October 2019 regarding the potential therapeutic benefits of LSD, psilocybin and other psychedelic agents. (The interview is at: https://www.thehealthcarepolicypodcast.com/2019/11/dr-rick-doblin-discusses-the-therapeutic-potential-of-psychedelics-october-31st-.html
Phase 3 Study of MDMA Proves Clinically Effective (May 10th)
Phase 3 Study of MDMA Proves Clinically…
Phase 3 Study of MDMA Proves Clinically Effective (May 10th)
Listeners may recall I interviewed Dr. Rick Doblin in October 2019 regarding the potential therapeutic benefits of LSD, psilocybin and other psychedelic agents. (The interview is at: https://www.thehealthcarepolicypodcast.com/2019/11/dr-rick-doblin-discusses-the-therapeutic-potential-of-psychedelics-october-31st-.html